Medical Device News Magazine

Innovation in Technology Sparks Growth in Consumer Genomics: North America Leads While Asia-Pacific Gears Up for Rapid Expansion

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The global consumer genomics market is set to witness substantial growth, with revenues projected to increase from $2.42 billion in 2022 to $2.90 billion in 2023, propelled by a strong compound annual growth rate (CAGR) of 19.55%. The market is anticipated to continue its upward trajectory and is forecasted to reach $6.00 billion by 2027, with a CAGR of 19.94%.

Key players in the consumer genomics market include 23andMe Inc., Gene By Gene Ltd., Mapmygenome Ltd., Ancestry.com LLC, Color Genomics Inc., Futura Genetics, Pathway Genomics, Helix OpCo LLC, Positive Biosciences Ltd., Veritas Genetics, Illumina Inc., MyHeritage Ltd., Myriad Genetics Inc., Amgen Inc., Diagnomics Inc., Illumina, Inc., MyHeritage Ltd., Positive Biosciences Ltd., Toolbox Genomics, and Xcode Life.

Reasons to Purchase

  • Gain a comprehensive global perspective on the consumer genomics market, covering 50+ geographies.
  • Understand the market’s response to the COVID-19 pandemic.
  • Assess the impact of the RussiaUkraine war on agriculture, energy, and mineral commodity supply.
  • Measure the influence of high global inflation on market growth.
  • Create regional and country strategies based on local data and analysis.
  • Identify promising growth segments for investment.
  • Leverage forecast data and market trends to outperform competitors.
  • Stay informed about customer preferences based on the latest market shares.
  • Benchmark your company’s performance against key competitors.
  • Access data from the report in an Excel dashboard format.

Consumer Genomics Market Overview

Consumer genomics focuses on providing genetic information directly to consumers through commercial genetic testing services. These services utilize DNA samples provided by individuals to generate reports offering insights into genetic predispositions to traits, diseases, or conditions.

Key product categories in consumer genomics include consumables, systems and software, and other products. Consumables comprise products and materials used in genetic testing, such as collection kits, reagents, and laboratory supplies. Technologies employed include polymerase chain reaction (PCR), sequencing, microarray, nucleic acid extraction and purification. Consumer genomics applications span genetic relatedness, diagnostics, lifestyles, ancestry, wellness and nutrition, reproductive health, personalized medicine and pharmacogenetic testing, sports nutrition and health, among others.

Key Market Trends

Technological advancements are a prominent trend in the consumer genomics market, with leading companies focusing on innovation to enhance their capabilities and maintain a competitive edge.

Recent Acquisition

In [Month, Year], [Company Name], a US-based genetic testing company, completed the acquisition of [Acquired Company Name] for [Acquisition Amount]. This strategic move aimed to [Briefly explain the purpose and benefits of the acquisition, such as expanding product offerings, entering new markets, or enhancing technological capabilities].

Regional Insights

In 2022, North America emerged as the largest region in the consumer genomics market, while Asia-Pacific is expected to experience the fastest growth during the forecast period. The report encompasses regions including Asia-PacificWestern EuropeEastern EuropeNorth AmericaSouth America, and the Middle East and Africa.

Growing Applications of DTC Genomics

The increasing applications of Direct-to-Consumer (DTC) genomics in diagnostics, genetic relatedness, sports nutrition, personalized medicines, and other fields are expected to drive the growth of the consumer genomics market. DTC genomics test kits enable individuals to gain insights into their genetic makeup and health risks from the comfort of their homes. For instance, prenatal paternity genomics testing witnessed a 47.0% surge in demand in 2021 compared to pre-pandemic levels, highlighting the growing adoption of DTC genomics in diagnostics.

Key Topics Covered:

1. Executive Summary

2. Consumer Genomics Market Characteristics

3. Consumer Genomics Market Trends And Strategies

4. Consumer Genomics Market – Macro Economic Scenario
4.1. COVID-19 Impact On Consumer Genomics Market
4.2. Ukraine-Russia War Impact On Consumer Genomics Market
4.3. Impact Of High Inflation On Consumer Genomics Market

5. Consumer Genomics Market Size And Growth
5.1. Global Consumer Genomics Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Consumer Genomics Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Consumer Genomics Market Segmentation
6.1. Global Consumer Genomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Consumables
  • Systems And Software
  • Other Products

6.2. Global Consumer Genomics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Polymerase Chain Reaction (PCR)
  • Sequencing
  • Microarray
  • Nucleic Acid Extraction And Purification

6.3. Global Consumer Genomics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Genetic Relatedness
  • Diagnostics
  • Lifestyle
  • Ancestry
  • Wellness And Nutrition
  • Reproductive Health
  • Personalized Medicine And Pharmacogenetic Testing
  • Sports Nutrition And Health
  • Other Applications

7. Consumer Genomics Market Regional And Country Analysis
7.1. Global Consumer Genomics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Consumer Genomics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”